The latest research from Fore Pharma, Japan Huntington's Disease Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Huntington's Disease pipeline products, Huntington's Disease epidemiology, Huntington's Disease market valuations and forecast, Huntington's Disease products sales and competitive landscape in Japan.
The research is classified into nine sections – Huntington's Disease overview including etiology, pathophysiology, and diagnosis, Huntington's Disease treatment options, Huntington's Disease pipeline products, Huntington's Disease market analysis comprising of Huntington's Disease epidemiology, key products marketed for Huntington's Disease, market valuations and forecast, products sales and market shares.
Research Scope: - Huntington's Disease Pipeline: Find out the products in clinical trials for the treatment of Huntington's Disease by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products - Huntington's Disease Epidemiology: Find out the number of patients diagnosed (prevalence) with Huntington's Disease in Japan - Huntington's Disease Products: Identify key products marketed and prescribed for Huntington's Disease in Japan, including trade name, molecule name, and company - Huntington's Disease Product Sales: Find out the sales revenues of Huntington's Disease products, both branded and generics, in Japan - Huntington's Disease Market Valuations: Find out the market size for Huntington's Disease products in 2015 in Japan. Find out how the market advanced from 2010 and forecast to 2020 - Huntington's Disease Products Market Share: Find out the market shares for key Huntington's Disease products in Japan
Benefits of this Research: The research helps executives to - Support monitoring and reporting national Huntington's Disease market analysis and sales trends - Track competitor drugs sales and market share in Japan Huntington's Disease market - Track competitive developments in Huntington's Disease market and present key issues and learnings - Synthesize insights for Huntington's Disease market and products to drive business performance - Answer key business questions about the Huntington's Disease market - Evaluate commercial market opportunity assessment, positioning, and segmentation for Huntington's Disease products - Supports decision making in R&D to long term marketing strategies
Our reports have been used by over 10K customers, including:
190 pages •
By Global Industry Analysts
• Apr 2021
- Global Mental Health and Intellectual Disability Facilities Market to Reach $239.6 Billion by 2027
- Amid the COVID-19 crisis, the global market for Mental Health and Intellectual Disability Facilities estimated at US$172.9 Billion in the year 2020, is projected to reach a revised size of US$239.6 Billion...
116 pages •
By Asia Market Information & Development Company
• Sep 2020
This study focuses on China’s Central Nervous System Disorder Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one...
BDNF/NT 3 Growth Factors Receptor - Pipeline Review, H2 2019
BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 18.104.22.168) pipeline Target constitutes close to 23 molecules....
BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 22.214.171.124) - Pipeline Review, H1 2019 Summary According to the recently published report ’BDNFNT 3 Growth Factors Receptor - Pipeline...
Black Swan Analysis Epiomic™ Epidemiology Forecast Report on Autism Spectrum Disorders in 22 Major Markets Autism Spectrum Disorders (ASD) or Pervasive Developmental Disorder (PDD) defines a group of developmental disability disorders. These disorders include: Autism, Pervasive Developmental Disorder not otherwise specified (PDD-NOS), Asperger...
5-Hydroxytryptamine Receptor 6 (5 HT6 or Serotonin Receptor 6 or HTR6) - Pipeline Review, H1 2018 Summary 5-Hydroxytryptamine Receptor 6 (5 HT6 or Serotonin Receptor 6 or HTR6) pipeline Target constitutes close to 21 molecules. Out of which approximately 20 molecules are developed by companies and...
Report Details Uncommon nerve disorders - new study explains technological and commercial prospects What's the future of medicines for rare central nervous system (CNS) disorders? Visiongain's new report gives you predictions for those therapies. Stay ahead. There you explore sales results, technologies, R&D trends, opportunities,...
Research And Development
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.